Corticosteroid-Associated Avascular Necrosis of the Femoral Head in Patients with Severe COVID-19: A Single-Center Study
- PMID: 37431094
- PMCID: PMC10349538
- DOI: 10.12659/MSM.940965
Corticosteroid-Associated Avascular Necrosis of the Femoral Head in Patients with Severe COVID-19: A Single-Center Study
Abstract
BACKGROUND Avascular necrosis (AVN) of the femoral head can result from high-dose corticosteroid therapy. Given that severe COVID-19 pneumonia patients respond positively to corticosteroids, this study aimed to explore the incidence of femoral head AVN associated with corticosteroid therapy in 24 patients diagnosed with severe COVID-19 at a single center. MATERIAL AND METHODS The study included 24 patients who were diagnosed with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection through real-time reverse transcription polymerase chain reaction test (rRT-PCR) and with COVID-19 pneumonia via high-resolution computed tomography (HRCT). Moderate cases received 2×4 mg Dexamethasone while severe cases were also administered with 3×40 mg Methylprednisolone. Diagnosis of femoral head AVN was confirmed with magnetic resonance imaging (MRI) and radiographs, which was subsequently treated by a total hip arthroplasty (THA) or a core decompression surgery (CDS) in line with the Ficat and Arlet classifications RESULTS Among the patients, 8 had a moderate infection course, while 16 were severe. The mean corticosteroid duration was 15±5 days for Dexamethasone and 30 days for Methylprednisolone. Severe patients presented with higher grade femoral head AVN and greater pain levels compared to moderate cases (p<0.05). Four patients developed bilateral AVN. The treatment resulted in 23 THAs and 5 CDSs CONCLUSIONS The data from this study corroborate earlier studies and case reports, suggesting an increased occurrence of AVN of the femoral head during the COVID-19 pandemic due to the high-dose corticosteroid therapy employed for patients hospitalized with severe COVID-19 pneumonia.
Conflict of interest statement
Figures




Similar articles
-
MRI spectrum of avascular necrosis of femoral head in patients treated for COVID-19.Hip Int. 2024 Jul;34(4):510-515. doi: 10.1177/11207000241233906. Epub 2024 Mar 8. Hip Int. 2024. PMID: 38456448
-
Corticosteroid-associated osteonecrosis of the femoral head in an 87-year-old patient following treatment for COVID-19-associated pneumonia: A case report.Skeletal Radiol. 2024 Dec;53(12):2741-2744. doi: 10.1007/s00256-024-04673-9. Epub 2024 Apr 8. Skeletal Radiol. 2024. PMID: 38589632
-
[Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence].Zhonghua Yi Xue Za Zhi. 2004 Aug 17;84(16):1348-53. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15387943 Chinese.
-
Avascular necrosis of the femoral head after single steroid intra-articular injection.Eur J Orthop Surg Traumatol. 2020 Feb;30(2):193-197. doi: 10.1007/s00590-019-02555-8. Epub 2019 Sep 19. Eur J Orthop Surg Traumatol. 2020. PMID: 31538269 Review.
-
The pandemic is gone but its consequences are here to stay: avascular necrosis following corticosteroids administration for severe COVID-19.J Orthop Surg Res. 2024 Feb 12;19(1):135. doi: 10.1186/s13018-024-04556-8. J Orthop Surg Res. 2024. PMID: 38347592 Free PMC article.
Cited by
-
Effect of platelet-rich plasma combined with simvastatin in the treatment of steroid-induced avascular necrosis of the femoral head.Pak J Med Sci. 2025 May;41(5):1280-1284. doi: 10.12669/pjms.41.5.11518. Pak J Med Sci. 2025. PMID: 40469146 Free PMC article.
-
Letter to the editor regarding "osteonecrosis of the femoral head in post-COVID-19 patients: a retrospective comparative study".J Orthop Surg Res. 2025 Jun 5;20(1):573. doi: 10.1186/s13018-025-05871-4. J Orthop Surg Res. 2025. PMID: 40474224 Free PMC article.
-
Osteonecrosis of the femoral head in post-COVID-19 patients: a retrospective comparative study.J Orthop Surg Res. 2025 Apr 10;20(1):362. doi: 10.1186/s13018-025-05657-8. J Orthop Surg Res. 2025. PMID: 40211352 Free PMC article.
-
A Comprehensive Review of COVID-19-Infection- and Steroid-Treatment-Associated Bone Avascular Necrosis: A Multi-Study Analysis.Diagnostics (Basel). 2024 Jan 24;14(3):247. doi: 10.3390/diagnostics14030247. Diagnostics (Basel). 2024. PMID: 38337763 Free PMC article. Review.
-
Post-COVID-19 Femoral Head Osteonecrosis Exhibits Mast Cell Clusters, Fibrosis, and Vascular Thrombosis: Key Pathological Mechanisms in Long COVID-19 Bone Degeneration.Pathophysiology. 2025 Jul 18;32(3):36. doi: 10.3390/pathophysiology32030036. Pathophysiology. 2025. PMID: 40700078 Free PMC article.
References
-
- COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health; Accessed at https://www.covid19treatmentguidelines.nih.gov/ - PubMed
-
- Ye Z, Wang Y, Colunga-Lozano LE, et al. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: A systematic review and meta-analysis. CMAJ. 2020;192(27):E756–E767. - PMC - PubMed
-
- Barney J, Piuzzi NS, Akhondi H. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. Femoral head avascular necrosis. Accessed at: https://www.ncbi.nlm.nih.gov/books/NBK546658. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous